Annual CFI
$75.65 M
-$16.40 M-17.81%
December 31, 2024
Summary
- As of March 12, 2025, AMLX annual cash flow from investing activities is $75.65 million, with the most recent change of -$16.40 million (-17.81%) on December 31, 2024.
- During the last 3 years, AMLX annual CFI has risen by +$122.06 million (+263.03%).
- AMLX annual CFI is now -17.81% below its all-time high of $92.05 million, reached on December 31, 2023.
Performance
AMLX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$64.98 M
+$26.16 M+67.41%
December 31, 2024
Summary
- As of March 12, 2025, AMLX quarterly cash flow from investing activities is $64.98 million, with the most recent change of +$26.16 million (+67.41%) on December 31, 2024.
- Over the past year, AMLX quarterly CFI has increased by +$44.05 million (+210.54%).
- AMLX quarterly CFI is now -47.27% below its all-time high of $123.22 million, reached on June 30, 2023.
Performance
AMLX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$75.65 M
+$44.05 M+139.42%
December 31, 2024
Summary
- As of March 12, 2025, AMLX TTM cash flow from investing activities is $75.65 million, with the most recent change of +$44.05 million (+139.42%) on December 31, 2024.
- Over the past year, AMLX TTM CFI has dropped by -$16.40 million (-17.81%).
- AMLX TTM CFI is now -17.81% below its all-time high of $92.05 million, reached on December 31, 2023.
Performance
AMLX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
AMLX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.8% | +210.5% | -17.8% |
| 3 y3 years | +263.0% | +160.1% | +148.2% |
| 5 y5 years | +100.0% | +160.1% | +148.2% |
AMLX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -17.8% | +131.7% | -47.3% | +128.5% | -17.8% | +131.7% |
| 5 y | 5-year | -17.8% | +131.7% | -47.3% | +128.5% | -17.8% | +131.7% |
| alltime | all time | -17.8% | +131.7% | -47.3% | +128.5% | -17.8% | +131.7% |
Amylyx Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $75.65 M(-17.8%) | $64.98 M(+67.4%) | $75.65 M(+139.4%) |
| Sep 2024 | - | $38.82 M(-234.0%) | $31.60 M(-127.4%) |
| Jun 2024 | - | -$28.96 M(-3636.1%) | -$115.31 M(-412.7%) |
| Mar 2024 | - | $819.00 K(-96.1%) | $36.88 M(-59.9%) |
| Dec 2023 | $92.05 M(-138.5%) | $20.93 M(-119.4%) | $92.05 M(-158.6%) |
| Sep 2023 | - | -$108.09 M(-187.7%) | -$157.05 M(-547.7%) |
| Jun 2023 | - | $123.22 M(+120.1%) | $35.08 M(-141.9%) |
| Mar 2023 | - | $55.99 M(-124.5%) | -$83.68 M(-65.0%) |
| Dec 2022 | -$238.99 M | -$228.18 M(-371.5%) | -$238.99 M(+2889.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $84.04 M(+1783.5%) | -$7.99 M(-94.3%) |
| Jun 2022 | - | $4.46 M(-104.5%) | -$141.24 M(-3.1%) |
| Mar 2022 | - | -$99.31 M(-3629.2%) | -$145.70 M(+214.0%) |
| Dec 2021 | -$46.41 M(>+9900.0%) | $2.81 M(-105.7%) | -$46.41 M(-5.7%) |
| Sep 2021 | - | -$49.21 M(<-9900.0%) | -$49.22 M(>+9900.0%) |
| Jun 2021 | - | $0.00(-100.0%) | -$14.00 K(0.0%) |
| Mar 2021 | - | -$14.00 K | -$14.00 K |
| Dec 2020 | -$151.00 K(<-9900.0%) | - | - |
| Dec 2019 | $0.00 | - | - |
FAQ
- What is Amylyx Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals annual CFI year-on-year change?
- What is Amylyx Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals quarterly CFI year-on-year change?
- What is Amylyx Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals TTM CFI year-on-year change?
What is Amylyx Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of AMLX is $75.65 M
What is the all time high annual CFI for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high annual cash flow from investing activities is $92.05 M
What is Amylyx Pharmaceuticals annual CFI year-on-year change?
Over the past year, AMLX annual cash flow from investing activities has changed by -$16.40 M (-17.81%)
What is Amylyx Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of AMLX is $64.98 M
What is the all time high quarterly CFI for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high quarterly cash flow from investing activities is $123.22 M
What is Amylyx Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, AMLX quarterly cash flow from investing activities has changed by +$44.05 M (+210.54%)
What is Amylyx Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of AMLX is $75.65 M
What is the all time high TTM CFI for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high TTM cash flow from investing activities is $92.05 M
What is Amylyx Pharmaceuticals TTM CFI year-on-year change?
Over the past year, AMLX TTM cash flow from investing activities has changed by -$16.40 M (-17.81%)